ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

15,457Medicare Part D Prescriptions Filled, Including Refills

Rank: 23 out of 1269

$1.4M Total Retail Price of All Prescriptions

Rank: 6 out of 1269

609 Patients Receiving at Least One Drug in Part D
95%Patients 65 Years and Older
77% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Maryland
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

3% of this provider’s 609 patients filled at least one prescription for a schedule three drug, compared to an average of 5%.

Risky Drugs to Seniors

1% of this provider’s 15,143 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

37% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$90 was the average price of a prescription from this provider, compared to $69 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Maryland
ALENDRONATE SODIUM 775 766 1 28
AMLODIPINE BESYLATE 745 744 2 2
LIDODERM 561 559 3 56
PRAVASTATIN SODIUM 421 417 4 11
ATORVASTATIN CALCIUM 407 402 5 7
NEXIUM 387 387 6 41
SIMVASTATIN 364 353 7 3
METFORMIN HCL ER 355 352 8 80
OMEPRAZOLE 350 339 9 8
METOPROLOL SUCCINATE 344 344 10 13
DIOVAN 328 328 11 35
LEVOTHYROXINE SODIUM 297 288 12 4
NAMENDA 282 282 13 38
DIOVAN HCT 268 268 14 76
RANITIDINE HCL 260 258 15 27
LISINOPRIL 243 222 16 1
JANUVIA 226 222 17 74
TAMSULOSIN HCL 209 205 18 31
LOSARTAN POTASSIUM 195 188 19 15
ATENOLOL 184 184 20 14
PANTOPRAZOLE SODIUM 166 164 21 18
EXELON 164 164 22 142
CLOPIDOGREL 143 138 23 32
GLYSET 141 141 10 24 286
METFORMIN HCL 139 139 25 9
SERTRALINE HCL 130 126 26 23
DONEPEZIL HCL 126 126 27 22
PLAVIX 125 123 28 47
LYRICA 125 125 28 92
LISINOPRIL-HYDROCHLOROTHIAZIDE 122 116 30 33
LIPITOR 122 122 30 91
CITALOPRAM HBR 115 103 32 21
CRESTOR 107 107 33 25
GLIMEPIRIDE 105 101 34 57
HYDROCHLOROTHIAZIDE 105 104 34 10
PREDNISONE 104 99 36 45
LANSOPRAZOLE 96 96 37 120
FLUOXETINE HCL 96 92 37 83
AZITHROMYCIN 96 93 37 42
FUROSEMIDE 88 88 40 5
PROPRANOLOL HCL 87 87 41 227
BENAZEPRIL HCL 84 84 42 156
ESCITALOPRAM OXALATE 83 83 43 58
ALLOPURINOL 83 78 43 49
PAROXETINE HCL 83 83 43 71
ADVAIR DISKUS 81 81 46 46
LOSARTAN-HYDROCHLOROTHIAZIDE 80 80 47 59
LOVASTATIN 80 78 47 30
ACARBOSE 79 79 49 284
CELEBREX 78 78 50 95
ACTONEL 77 77 51 229
MIRTAZAPINE 77 77 51 24
TRAZODONE HCL 75 75 53 36
FLUTICASONE PROPIONATE 75 71 53 40
FINASTERIDE 74 74 55 112
LANTUS 72 72 56 39
ZOSTAVAX 70 67 57 202
GLYBURIDE-METFORMIN HCL 67 67 R 58 172
BUPROPION XL 66 66 59 239
SPIRONOLACTONE-HCTZ 61 57 60 228
METOPROLOL TARTRATE 60 51 61 6
COLCRYS 60 46 61 150
TRIAMTERENE-HCTZ 57 55 63 69
WARFARIN SODIUM 56 56 64 12
METHOTREXATE 56 51 64 188
AVODART 56 56 64 298
GLYBURIDE 55 55 R 67 94
ISOSORBIDE MONONITRATE ER 54 53 68 63
ZETIA 54 54 68 99
TRIAMCINOLONE ACETONIDE 52 50 70 131
NATEGLINIDE 52 52 70 383
PEN NEEDLE 51 51 72 215
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 12, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.